Clinical trials
Terminated Triple Negative Breast Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 2 |
| Novartis Pharmaceuticals | 2 |
| Pfizer | 2 |
| ADC Therapeutics S.A. | 1 |
| Amgen | 1 |
| Ayala Pharmaceuticals, Inc, | 1 |
| BerGenBio ASA | 1 |
| Calithera Biosciences, Inc | 1 |
| GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | 1 |
| Genmab | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 20 |
| Carcinoma, Non-Small-Cell Lung | 10 |
| Squamous Cell Carcinoma of Head and Neck | 7 |
| Stomach Neoplasms | 7 |
| Carcinoma, Renal Cell | 6 |
| Melanoma | 5 |
| Ovarian Neoplasms | 4 |
| Esophageal Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
| Urinary Bladder Neoplasms | 3 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.